Obesidad: un problema en la atención de Covid-19
Obesity: a problem in Covid-19 care
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Mostrar biografía de los autores
Actualmente el mundo atraviesa una de las peores crisis a nivel salud secundario a la infección por un nuevo coronavirus de alta transmisibilidad y mortalidad, que ha impactado múltiples aspectos. Se ha establecido de forma general que la severidad de la infección está asociada con edad avanzada y comorbilidades como hipertensión y diabetes. Por otro lado, la obesidad en este momento representa una de las mayores amenazas del sector salud, por su gran relación con morbimortalidad a nivel cardiometabólico, esto conlleva a un alto costo de la enfermedad. Este artículo busca alertar sobre lo que han llamado algunos expertos el “choque de dos pandemias”, esto dado al aumento de la prevalencia de obesidad a nivel mundial, donde nuestro país no está exento, que podría relacionarse con un número mayor de personas vulnerables a la infección por COVID-19 y sus complicaciones respiratorias y de esta manera evitar desenlaces catastróficos.
Visitas del artículo 14622 | Visitas PDF 12856
- Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation [Internet]. 2020;2019. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/32200663 doi: 10.1161/CIRCULATIONAHA.120.046941
- The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team [corresponding author Yanping Zhang]. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Wkly. 2020;2(8):113–22.
- Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Metab. 2006;290(6):E1253-61 doi: 10.1152/ajpendo.00572.2004
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. doi: 10.1016/S0140-6736(20)30566-3
- Centers for Disease Control and Prevention. People at High Risk For Flu Complications [Internet]. 2020. Disponible en: https://www.cdc.gov/flu/highrisk/index.htm
- Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA - J Am Med Assoc. 2009;302(17):1896–902. doi: 10.1001/jama.2009.1583
- Venkata C, Sampathkumar P, Afessa B. Hospitalized patients with 2009 H1N1 influenza infection: The mayo clinic experience. Mayo Clin Proc. 2010;85(9):798–805. doi: 10.4065/mcp.2010.0166
- Thompson DL, Jungk J, Hancock E, Smelser C, Landen M, Nichols M, et al. Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico. Am J Public Health. 2011;101(9):1776–84. doi: 10.2105/AJPH.2011.300223
- Mexico G de. Comunicado Tecnico Diario COVID-19- Reporte 29 de marzo [Internet]. 2020. Disponible en: https://coronavirus.gob.mx/noticias/
- Instituto nacional de Salud C. COVID 19 Colombia-Reporte 30 de marzo [Internet]. 2020. Disponible en: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx
- Ministerio de Salud y Protección Social – Colombia. Encuesta Nacional de la Situación Nutricional ENSIN 2015 [Internet]. 2017. Disponible en: https://www.minsalud.gov.co/Paginas/Gobierno-presenta-Encuesta-Nacional-de-Situación-Nutricional-de-Colombia-ENSIN-2015.aspx
- Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, et al. Cytokine release syndrome. J Immunother Cancer. 2018;6(1):56. doi: 10.1186/s40425-018-0343-9
- Liu E, Marin D, Banerjee P, MacApinlac HA, Thompson P, Basar R, et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N Engl J Med. 2020;382(6):545–53. doi: 10.1056/NEJMoa1910607
- Wang W, He J, Lie puyi, Huang liyan, Wu S, lin yongping, et al. The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective analysis. medRxiv. 2020. doi: https://doi.org/10.1101/2020.02.26.20026989.
- Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019. J Clin Invest. 2020;pii: 137244. doi: 10.1172/JCI137244
- Rakotoarivelo V, Variya B, Langlois MF, Ramanathan S. Chemokines in human obesity. Cytokine [Internet]. 2020;127:154953. Available from: https://doi.org/10.1016/j.cyto.2019.154953
- Aasheim ET, Hofsø D, Hjelmesœth J, Birkeland KI, Bøhmer T. Vitamin status in morbidly obese patients: A cross-sectional study. Am J Clin Nutr. 2008;87(2):362–9. doi: 10.1093/ajcn/87.2.362
- Molnár D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes. 2004;28(10):1197–202. oi: 10.1038/sj.ijo.0802719
- Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35(8):627–31. doi: 10.1016/s0009-9120(02)00363-6
- Arnaud J, Bertrais S, Roussel AM, Arnault N, Ruffieux D, Favier A, et al. Serum selenium determinants in French adults: the SU.VI.M.AX study. Br J Nutr. 2006;95(2):313–20. doi: 10.1079/bjn20051528
- Ferrante AW. Obesity-induced inflammation: A metabolic dialogue in the language of inflammation. J Intern Med. 2007;262(4):408–14. doi: 10.1111/j.1365-2796.2007.01852.x
- Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes. 2000;24(Suppl. 4):S23–7. doi: 10.1038/sj.ijo.0801497
- Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28(7):1304–10. doi: 10.1161/ATVBAHA.108.165100
- O’Rourke RW, Kay T, Scholz MH, Diggs B, Jobe BA, Lewinsohn DM, et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg. 2005;15(10):1463–8. doi: 10.1381/096089205774859308
- Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine. 2012;30(26):3937–43. doi: 10.1016/j.vaccine.2012.03.071
- Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119(7 Pt 2):655–60. doi: 10.7326/0003-4819-119-7_part_2-199310011-00006
- Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity (Silver Spring) [Internet]. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32237206